Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Electronic Patient Reporting of Symptoms During Cancer Treatment
- Status
- COMPLETED
- Phase
- NA
Nivolumab Plus Ipilimumab in Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Post-Operative Ambulatory Challenge and Exercise (PACE) Trial
- Status
- COMPLETED
- Phase
- NA
An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study
- Status
- COMPLETED
- Phase
- NA
Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Palbociclib After CDK and Endocrine Therapy (PACE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
- Status
- TERMINATED
- Phase
- PHASE2
Cyclophosphamide and Alemtuzumab In Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1